From the November 2022 issue of HealthCare Business News magazine
As the healthcare industry continues to grow more familiar with what artificial intelligence is, as well as what it isn’t, new research is providing an increasingly clear-eyed look at how deep learning could fundamentally change medicine. Here, presented in chronological order, are the ten most-read AI stories of the year from our Daily News online.
IBM sells Watson Health to investment firm Francisco Partners
In January, global investment firm Francisco Partners bought the data and analytics business of IBM’s Watson Health.
The company took various parts of Watson Health, including Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex and Imaging Software Offerings. This gives it access to a broad array of health data, which it plans to use to create a new stand-alone company. It also will retain IBM’s management team for the data and analytics business, according to TechCrunch.
While neither company disclosed terms, previous reports said IBM was aiming to take away $1 billion from the sale. "Today's agreement with Francisco Partners is a clear next step, as IBM becomes even more focused on our platform-based hybrid cloud and AI strategy. IBM remains committed to Watson, our broader AI business, and to the clients and partners we support in healthcare IT,” Tom Rosamilia, IBM Software's senior vice president, said in a statement.
The current management team will continue to serve in similar roles as part of the new company and serve existing clients in life sciences, provider, imaging, payer and employer, and government health and human services sectors.
Francisco Partners will also add additional support to the new company. “Partnering with corporations to execute divisional carve-outs has been a core focus of Francisco Partners,” said Justin Chen, principal at Francisco Partners.
